Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

: Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use - JSON Representation

Raw json | Download

{
  "resourceType" : "RegulatedAuthorization",
  "id" : "authherceptin150",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization authherceptin150</b></p><a name=\"authherceptin150\"> </a><a name=\"hcauthherceptin150\"> </a><a name=\"authherceptin150-en-US\"> </a><p><b>identifier</b>: <code>https://pmda-approvalandlicenseno/</code>/21300AMY00128\u00a0(use:\u00a0official,\u00a0)</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-medprodherceptin150.html\">MedicinalProductDefinition: identifier = http://iyaku.info/medicine#4291447D2024; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi/ /#100000072062}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{urn:iso:std:iso:3166 JP}\">Japan</span></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><p><b>statusDate</b>: 2002-08-01 13:28:17+0000</p><p><b>holder</b>: <a href=\"Organization-orgchugai.html\">Organization Chugai Pharmaceutical Co., Ltd.</a></p></div>"
  },
  "identifier" : [
    {
      "use" : "official",
      "system" : "https://pmda-approvalandlicenseno/",
      "value" : "21300AMY00128"
    }
  ],
  "subject" : [
    {
      🔗 "reference" : "MedicinalProductDefinition/medprodherceptin150"
    }
  ],
  "type" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/rmswi/",
        "code" : "/#100000072062"
      }
    ],
    "text" : "Marketing Authorisation"
  },
  "region" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "JP"
        }
      ],
      "text" : "Japan"
    }
  ],
  "status" : {
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/publication-status",
        "code" : "active"
      }
    ],
    "text" : "Active"
  },
  "statusDate" : "2002-08-01T13:28:17Z",
  "holder" : {
    🔗 "reference" : "Organization/orgchugai"
  }
}